KM

Kyle D. Monroe

SC Srx Cardio: 11 patents #3 of 11Top 30%
Overall (All Time): #367,906 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11944619 Phenylalanine small organic compounds to directly modulate PCSK9 protein activity Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers 2024-04-02
11945782 Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers 2024-04-02
11925637 Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers 2024-03-12
11771710 Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann 2023-10-03
11026957 Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann 2021-06-08
10980801 Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers 2021-04-20
10865185 Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers 2020-12-15
10821106 Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers 2020-11-03
10688114 Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann 2020-06-23
10568882 Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann, Anjali Pandey, Simeon Bowers 2020-02-25
10307433 Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann 2019-06-04
10287317 Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels Michael M. Muehlemann, Thomas E. Barta, Jonathan William Bourne, Margaret Thompson Reece, Vesa Nevalainen +1 more 2019-05-14
10034892 Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity Thomas E. Barta, Jonathan William Bourne, Michael M. Muehlemann 2018-07-31